Publications on RNA Fragments
Interested in a specific ingredient perfected by Dr. Beljanski? For your convenience we have selected on one page all the scientific publications published by Dr. Beljanski on this specific ingredient, as well as the research papers resulting from the Beljanski Foundation’s partnerships. The goal of the Foundation is to share this knowledge and increase awareness about scientific research conducted on natural compounds. If you care about providing scientifically researched alternatives to chemical drugs, please support the Beljanski Foundation’s research program.
Low platelet counts, a condition called thrombocytopenia, is a side effect of chemo drugs that damage the bone marrow stem cells that normally produce platelets. This Phase I trial showed that Beljanski’s RNA fragments could prevent thrombocytopenia by inducing the production of new platelets. Patients taking the RNA fragments had their platelet levels return to normal and chemotherapy treatments were completed without dose reductions, platelet transfusions, or suspensions. The RNA fragments protected platelet levels in patients with many different types of cancer who were taking many different anti-cancer drugs. Moreover, patients did not suffer any negative side effects as a result of taking the RNA fragments.
Mirko Beljanski's publications
As he was developing his extracts Dr. Mirko Beljanski referred to RNA fragments as R.L.B.
79. M. BELJANSKI, M. PLAWECKI, P. BOURGAREL, M. S. BELJANSKI, “Nouvelles substances (R.L.B.) actives dans la leucopoïese et la formation des plaquettes“. Bull. Acad. Nat. Med., 1978, 162, Volume n°6, pp. 475-781.
83. M. BELJANSKI, M. PLAWECKI, “Particular RNA Fragments as Promoters of Leukocyte and Platelet Formations in Rabbits“. Exp. Cell Biol., 1979, 47, pp. 218-225.
86. M. BELJANSKI, “Oligoribo-nucleotides, promoters of leucocyte and platelet genesis in animals depleted by anticancer drugs”. NCI-EORTC Symposium on nature, prevention and treatment of clinical toxicity of anticancer agents. Institut Bordet, Bruxelles, 1980. This publication is not available online.
87. M. BELJANSKI, M. PLAWECKI, P. BOURGAREL, M.S. BELJANSKI, “Short chain RNA fragments as promoters of leucocyte and platelet genesis in animals depleted by anti-cancer drugs”. In the Role of RNA in Development and Reproduction. Sec. Int. Symposium, april 25-30, 1980, pp.79-113. Science Press Beijing. M.C. Niu and H.H. Chuang Eds Van Nostrand Reinhold Company.
118. D. DONADIO, R. LORHO, J.E. CAUSSE, T. NAWROCKI, M. BELJANSKI,”RNA Fragments (RLB) and Tolerance of Cytostatic Treatments in Hematology: A Preliminary Study about Two Non-Hodgkin Malignant Lymphoma Cases“. Deutsche Zeitschrift für Onkologie, 23, 2, 1991, pp. 33-35.
119. M. BELJANSKI, ”Reverse Transcriptase in Bacteria: Small RNAs as Genetic Vectors and Biological Modulators“. Brazil. J. Genetics, 14, 4, 1991, pp. 873-896.
120. M. BELJANSKI, “Radioprotection of Irradiated Mice – Mechanisms and Synergistic Action of WR-2721 and R.L.B.”. Deutsche Zeitschrift für Onkologie, 23, 6, 1991, pp. 155-159.
121. M. BELJANSKI, ”Overview: BLRs as Inducers of In Vivo Leucocyte and Platelet Genesis“. Deutsche Zeitschrift für Onkologie, 24, 2, 1992, pp. 41-46.
Share